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Integrin-linked kinase (ILK) plays a role in integrin signaling-mediated extracellular matrix (ECM)–cell interactions and also acts as a
scaffoldproteininfunctionalfocaladhesionpoints.Inthepresentstudy,weinvestigatedtheexpressionandrolesofILKinhumanintestinal
epithelialcells(IECs)invivoandinvitro.Herein,wereportthatILKanditsscaffold-functioninteractingpartners,PINCH-1,a-parvin,and
b-parvin,areexpressedaccordingtoadecreasinggradientfromthebottomofthecrypt(proliferative/undifferentiated) compartmentto
the tip of the villus (non-proliferative/differentiated) compartment, closely following the expression pattern of the ECM/basement
membrane component ﬁbronectin. The siRNA knockdown of ILK in human IECs caused a loss of PINCH-1, a-parvin, and b-parvin
expression,alongwithasigniﬁcantdecreaseincellproliferationviaalossofcyclinD1andanincreaseinp27andhypophosphorylatedpRb
expression levels. ILK knockdown severely affected cell spreading, migration, and restitution abilities, which were shown to be directly
relatedtoadecreaseinﬁbronectindeposition.AllILKknockdown-induceddefectswererescuedwithexogenouslydepositedﬁbronectin.
Altogether,ourresultsindicatethatILKperformscrucialrolesinthecontrolofhumanintestinalcellandcrypt–villusaxishomeostasis—
especially with regard to basement membrane ﬁbronectin deposition—as well as cell proliferation, spreading, and migration.
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The integrin-linked kinase (ILK) is typically located in integrin-
mediated adhesion complexes formed within the context of
extracellular matrix (ECM)–cell interactions (Vouret-Craviari
et al., 2004;McDonaldet al., 2008). Althoughits Ser/Thrkinase
activity is engaged upon integrin binding, ILK also functions as a
scaffolding protein which mediates linkage of integrins to the
actin cytoskeleton (Sepulveda and Wu, 2006; McDonald et al.,
2008). To this effect, ILK not only directly associates with the
b1 integrin subunit but recruits the scaffold-interacting
partnersPINCH(-1or-2),aswellasonememberoftheparvin
family(a-,b-,org-parvin)inordertoconstituteaPINCH–ILK–
parvin (PIP) complex (Legate et al., 2006; Sepulveda and Wu,
2006; McDonald et al., 2008). In addition to creating a physical
link between integrins and the actin cytoskeleton, distinct PIP
complexes can recruit additional cytoskeletal scaffolding and
signaling molecules, such as Nck2, paxillin, a-PIX, and a-actinin
(Legate et al., 2006; Sepulveda and Wu, 2006; McDonald et al.,
2008). Interactions of PIP complexes with speciﬁc additional
partners either directly or indirectly activate key elements of
varioussignalingpathwayssuchasAktandmembersoftheRho
GTPase family, thus implicating ILK in various cell adhesion-
mediated processes such as spreading, migration, survival, and
proliferation (Legate et al., 2006; Sepulveda and Wu, 2006;
McDonald et al., 2008).
The human intestinal epithelium is an elegant biological
model for the study of the coordinated cell processes involved
in tissue homeostasis. Its rapid, continuous renewal consists of
spatially separated proliferative/undifferentiated and non-
proliferative/differentiated epithelial cell populations located,
respectively, in the crypts and the villi (Pageot et al., 2000;
Crosnier et al., 2006). The dynamic renewal of the intestinal
epitheliumisessentiallycharacterizedbyintestinalepithelialcell
(IEC)productionandmaturationinthecrypts,migrationoutof
the crypts onto the base of the villi and, thereafter, further
migration ofdifferentiated cellstothetip ofthevilli where they
are shed by anoı ¨kis (Crosnier et al., 2006). In humans,
functionality of the crypt–villus axis is already fully established
by mid-gestation (18–20 weeks) (Teller and Beaulieu, 2001;
Crosnier et al., 2006). As with all epithelia, the intestinal
epithelium interacts with a basement membrane (BM). The
intestinal BM directs several cell processes that are critical to
the homeostasis of the intestinal epithelium, such as
proliferation, migration, differentiation, and survival (Beaulieu,
1997; Simon-Assmann et al., 1998; Teller and Beaulieu, 2001).
Some ECM components, such as type IV collagen and the
laminins, are exclusive to BMs (Laurie et al., 1982; Simon-
Assmann et al., 1986; Beaulieu and Vachon, 1994; Beaulieu,
1997). In the intestine, these molecules are differentially
expressed along the crypt–villus axis and are consequently
believed to perform distinct roles in IEC processes (Simon-
Assmann et al., 1986; Beaulieu, 1997). Another major
component of ECMs and BMs is ﬁbronectin, a key player in the
establishment and maintenance of tissue morphology and in
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 2009 WILEY-LISS, INC.wound healing (Simon-Assmann et al., 1986; Ruoslahti, 1988;
MaoandSchwarzbauer,2005; Zhangetal., 2006).Inthehuman
intestine,ﬁbronectinisstronglyexpressedintheBMunderlying
thecryptcompartment,decreasinggraduallytowardsthetipof
the villus (Quaroni et al., 1978; Simon-Assmann et al., 1986;
Beaulieu et al., 1991). Fibronectin is produced, secreted, and
depositedbyintestinalcellsofbothepithelial andmesenchymal
origins (Quaroni et al., 1978; Laurie et al., 1982; Vachon et al.,
1995) and has been shown to contribute to many cell functions
in cells of different origins (Ruoslahti, 1988; Mao and
Schwarzbauer, 2005). The successful deposition of ﬁbronectin
into the BM relies upon its recognition by speciﬁc integrin
receptors, which mediate its unfolding in a process known as
ﬁbrillogenesis (Mao and Schwarzbauer, 2005). This process
exposes speciﬁc structural domains within ﬁbronectin which
then mediate the formation of the insoluble ﬁbronectin ﬁbrils
required for their deposition (Mao and Schwarzbauer, 2005).
Incidentally, ﬁbronectin deposition is characterized by the
formation of specialized ECM–cell contact structures called
ﬁbrillar adhesion points, which are generated through an
organized interplay between integrins, cytosolic proteins, and
actincytoskeleton(MaoandSchwarzbauer,2005).Whilesome
reports have implicated ILK in the deposition of ﬁbronectin
(Wu et al., 1998; Guo and Wu, 2002; Vouret-Craviari et al.,
2004;Assietal.,2008),andalthoughILKandPIPcomplexesare
foundwithin ﬁbrillar adhesion points (Guoet al., 2001; Vouret-
Craviari et al., 2004), the question remains open as to their
roles in ﬁbronectin BM deposition in the human intestine.
Similarly, the speciﬁc role of ILK in adhesion-mediated cell
processes remains to be fully understood in human IECs.
In the present study, we investigated the expression and
roles of ILK in human IECs in vivo and in vitro. Herein, we
report that the crypt–villus axis expression patterns of ILK,
PINCH-1, a-parvin, and b-parvin all follow the BM distribution
ofﬁbronectin,thatis,beinglargelypredominantinproliferative/
undifferentiated crypt IECs. Using an siRNA approach to
knockdown ILK, we demonstrated a role for ILK in the
maintenance of PIP complexes, as well as in the deposition of
ﬁbronectin by IECs, subsequently directly affecting their
spreading, migration, and cell-cycle progression. The
introduction of an exogenous ﬁbronectin matrix rescued the
ILK knockdown phenotype, further emphasizing the
importance of ILK in the organization of the intestinal crypt–
villusBM,aswellasprovidingafunctionalbasisforitssigniﬁcant
roles in human IEC cell processes.
Materials and Methods
Materials
Mouse primary antibodies used were directed against: ILK
(Western blot (WB): 1/1,000) (clone 3/ILK, BD Transduction
Laboratories, Franklin Lakes, NJ), PINCH (WB: 1/1,000,
immunoﬂuorescence (IF): 1/50, co-immunoprecipitation (Co-IP):
2mg/100mm dish) (clone 49/PINCH, BD Transduction
Laboratories), b-actin (WB: 1/75,000) (clone C4, Santa Cruz
Biotechnology,Inc.,SantaCruz,CA),FAK(WB:1/1,000)(clone77,
BD Transduction Laboratories), ﬁbronectin (WB: 1/500, IF: 1/50)
(HFN7.1,DevelopmentalStudiesHybridomaBank,IowaCity,IA),
vinculin (IF: 1/500) (clone 7F9, Chemicon International, Temecula,
CA), pRB (WB: 1/1,000) (clone G3-245, BD Pharmingen, San
Diego, CA), V5 tag (IF: 1/500) (Invitrogen, Eugene, OR), a-parvin
(WB: 1/10, IF: 1/2; 3B5; generous gift from C. Wu, University of
Pittsburgh), b-parvin (WB: 1/300) (11A5; generous gift from C.
Wu), and HA probe (Co-IP, 2mg/100mm dish) (Santa Cruz
Biotechnology,Inc.).Rabbitprimaryantibodiesusedweredirected
against: laminin (WB: 1/1,000, IF: 1/200) (EHS; Sigma–Aldrich,
Oakville, ON), a5 integrin (WB: 1/1,000) (AB1928, Millipore,
Temecula, CA), aV integrin (WB: 1/1,000) (AB1930, Millipore),
p21 (WB: 1/2,000) (Santa Cruz Biotechnology, Inc.), p27 (WB: 1/
2,000) (Santa Cruz Biotechnology, Inc.), and cyclin D1 (WB: 1/
5,000)(SantaCruzBiotechnology,Inc.).Secondaryantibodiesused
wereAlexa Fluor 647 goatanti-mouse(Invitrogen) and sheepanti-
mouserhodamineconjugate,sheepanti-rabbitFITCconjugate,and
TRITC-conjugated phalloidin (Chemicon International). All other
materials were purchased from Sigma–Aldrich, MP Biomedicals
(Aurora, OH), BD Biosciences (San Jose, CA), or Fisher Scientiﬁc
(St. Laurent, QC, Canada) except where otherwise speciﬁed.
Human IEC models and cell culture
Human intestinal epithelial cells (HIECs), which exhibit all the
morphological and functional characteristics of normal human
proliferative/undifferentiated crypt IECs, were generated from the
mid-gestation (18–20 weeks) human ileum and have been
characterizedelsewhere(PerreaultandBeaulieu,1996).TheHIEC
line Caco-2/15, a stable clone of the parental Caco-2 cell line
(ATCC, Manassas, VA), has been fully characterized in previous
studies (Beaulieu and Quaroni, 1991; Pageot et al., 2000). Caco-2/
15cellsundergoafullenterocyticdifferentiationprocessthattakes
place spontaneously upon reaching conﬂuence (0 days post-
conﬂuence; PC) and which is gradually completed by 25–30 days
PC. Differentiated Caco-2/15 cells exhibit all the morphological
andfunctionalcharacteristicsofmatureenterocytesincludingtheir
transcriptome(Pageotetal.,2000;Tremblayetal.,2006).HIECand
Caco-2/15 cells were routinely cultured in plastic dishes (100mm;
Falcon Plastics, Los Angeles, CA), and maintained as previously
described (Teller et al., 2007).
RNA interference, transfection, and transduction
AnsiRNAagainstILK(siILK) waspurchasedfromAmbion(Austin,
TX). A non-silencing negative control siRNA (siCNS) was
purchased from Qiagen (Mississauga, ON, Canada). One day prior
to transfection, 2 10
5cells were plated in 35mm dishes (Falcon
Plastics) and transfected with siRNAs (40mM ﬁnal concentration)
using the X-tremeGENE siRNA transfection reagent (Roche
Diagnostics, Laval, QC, Canada) for HIEC or HiPerfect (Qiagen)
for Caco-2/15 cells according to the manufacturers’ instructions.
Cellswereconsideredreadytobeusedinthevariousexperiments
48h post-transfection.
Alternately, HIEC cells were stably transduced with a cDNA
coding for a V5-tagged wtILK (a generous gift from S. Dedhar,
University of British Columbia, BC). The establishment of stably
transduced cell populations was performed according to a
retroviral strategy previously described (Escafﬁt et al., 2006).
Cell culture-deposited ECM preparations
Newly conﬂuent HIEC cells on plastic culture dishes were lysed
using a 27mM ammonium hydroxide (NH4OH) solution for 5min
at room temperature followed by incubation for 10min with
doubled distilled water under rotation to remove remaining cell
debris. The underlying insoluble matrix was recuperated in 1 
Laemmlibuffer(2.3%SDS,10%glycerol,0.001%bromophenolblue
in 62.5mM Tris–HCl, pH 6.8).
Exogenous ﬁbronectin assays
Human plasma ﬁbronectin (Chemicon International) in PBS (pH
7.4) was coated onto either culture dishes or glass coverslips
(12mm diameter) at 3mg/cm
2 for 2h at 378C. Any remaining
potential adhesion sites were blocked with 2% bovine serum
albumin (BSA)–PBS (pH 7.4) for 1h at 378C prior to plating cells.
Cell proliferation assays
Proliferation assays were performed using 5-bromo-2-
deoxyuridine (BrdU) incorporation. For each assay, 2 10
5
siRNA-transfected HIEC or Caco-2/15 cells were seeded into
35mm dishes and allowed to settle for 24h under normal culture
conditions. BrdU (10mM ﬁnal concentration) (Roche Diagnostics)
was added to the medium for 4h. Visualization of BrdU-positive
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and nuclei were stained with 10ng/ml of 40,6-diamidino-2-
phenylindole (DAPI). Preparations were viewed with a DMIRBE
microscope (Leica, Saint-Laurent, QC, Canada) equipped for
epiﬂuorescence and digital imaging (RTE/CCD Y/Hz-1300 cooled
camera, Princeton Instruments, Inc., Trenton, NJ). The
proliferation index was established by calculating the ratio of
positive BrdU-stained cells over the total number of DAPI-stained
cells 100.
Human intestinal tissue samples
Mid-gestation (20 weeks) human small intestine (ileum) specimens
wereobtainedfromnormalelectivepregnancyterminations.Adult
human small intestine (ileum) specimens were obtained from non-
diseasedtissue(atleast10cmfromlesions)ofresectedileumfrom
non-inﬂammatory pathologies (bowel obstruction, primary
lymphoma, or tumor). In all cases, only specimens obtained rapidly
(60minorless)wereused.Forsomeanalyses,mid-gestationileum
specimens were processed for the separation of the epithelium
from its underlying mesenchyme, as previously described
(Perreault et al., 1998). The project was in accordance with a
protocol approved by the Institutional Human Research Review
Committee of the Universite ´ de Sherbrooke for the use of human
material for research.
Indirect immunoﬂuorescence
The preparation and embedding of tissue samples for
cryosectioning were performed as described previously (Beaulieu,
1992). Cryosections (3-mm thick) were prepared, ﬁxed, and
stained for indirect IF as previously described (Beaulieu, 1992; Ni
etal.,2005).Bothprimaryandsecondaryantibodiesweredilutedin
PBS (pH 7.4) containing 5% non-fat powdered milk (BLOTTO) or
2% BSA. Some sections were counterstained with 0.01% Evan’s
blueinPBS(pH7.4),mountedinglycerol–PBS(9:1)containing0.1%
phenylenediamine and viewed with a Reichert Polyvar 2
microscope (Leica) equipped for epiﬂuorescence and digital
imaging(DFC300FXcamera;Leica).Cellsplatedonglasscoverslips
(12mm)werepreparedandprocessedforindirectIFaspreviously
described (Vachon and Beaulieu, 1995). Both primary and
secondary antibodies were diluted in PBS (pH 7.4) containing 5%
BLOTTO or 2% BSA. Nuclei were counterstained 2min at room
temperature with 10ng/ml DAPI–PBS (pH 7.4), samples were
mounted in glycerol–PBS (9:1) containing 0.1% phenylenediamine
and viewed with a DMRXA microscope (Leica) equipped for
epiﬂuorescence and digital imaging (RTE/CCD Y/Hz-1300 cooled
camera).
Protein complex co-immunoprecipitation
Cellswerewashedwithice-coldPBSandsolubilizedinice-coldlysis
buffer (10mM Tris–HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 1%
Triton X-100, and Complete Mini, EDTA-free protease inhibitor;
Roche Diagnostics) for 20min on ice, and then centrifuged for
15min at 13,000g. Samples were pre-cleared using protein G-
Sepharose (Invitrogen) for 1h at 48C. Primary antibodies were
added to the samples and incubated overnight at 48C followed by
the addition of protein G-Sepharose for 1h at 48C. Samples were
washed three times with lysis buffer and resuspended in 2 
Laemmli, for subsequent Western blotting analyses (see below).
Western blotting analyses
Cell cultures were lysed in 1  Laemmli, reduced with 5%
b-mercaptoethanol, and processed as previously described
(Ni et al., 2005). Total proteins (100mg/lane) were resolved by
SDS–PAGE on 12–15% gels, electrotransferred onto
nitrocellulose membranes (BioRad, Mississauga, ON) and probed
as described previously (Ni et al., 2005). Full-range molecular
mass markers (Full-Range Rainbow Markers, GE Healthcare, Baie
D’Urfe ´, QC, Canada) were used as standards. Immunoreactive
bands were visualized using the enhanced chemiluminescence
(ECL) method (GE Healthcare) according to the manufacturer’s
instructions.
Reverse transcriptase (RT)-polymerase chain reaction (PCR)
analyses
Total RNA was extracted using the TriPure isolation reagent
(Roche Diagnostics) according to the manufacturer’s instructions.
RT-PCR was performed as described previously (Ni et al., 2005).
Primers used were: for ILK, ILK-F: 50-AAG GTG CTG AAG GTT
CGA GA and ILK-R: 50-ATA CGG CAT CCA GTG TGT GA; for
a-parvin, a-parvin1: 50-CAA TTC GAC TCC CAG ACC AT, and
a-parvin2: 50-TGG TCG AAC AAG GTG TCA AA; for b-parvin,
b-parvin1: 50-AGGTCCTCCTCGACTGGA TT,andb-parvin2:
50-ACC GTC TGC AGC TTC TGT TT; for PINCH-1, PINCH1-F:
50-TCC CAA GCC CTG ATA ACA AC, and PINCH1-R: 50-GGG
CAA AGA GCA TCT GAA AG; for vimentin, vimentin-F: 50-AGA
TGG CCC TTG ACA TTG AG, and vimentin-R: 50-GGT CAT
CGT GAT GCT GAG AA; for E-cadherin, Ecad-1: 50-CCT TCC
TCCCAATACATCTCCC,andEcad-2:50-TCTCCGCCTCCT
TCTTCATC;forRPLPO(ribosomalprotein,large,P0),RPLPO-F:
50-GCA ATG TTG CCA GTG TCT G, and RPLPO-R: 50-GCC
TTG ACC TTT TCA GCA A. Each cycle was composed of
templatedenaturationat948Cfor45sec,primerannealingat608C
for 45sec, and elongation at 728C for 1min for 30 cycles.
Real-time PCR quantiﬁcation analyses
ForthequantitativeevaluationofRNAmessengerlevels,real-time
PCR (qPCR) was carried out as previously described (Ni et al.,
2005). The primers used for ILK and RPLPO were the same as
above. Other primers used were: for ﬁbronectin, FN-F: 50-GTT
GTT ACC GTG GGC AAC TC, and FN-R: 50-CTG ACG GTC
CCACTTCTCTC;forlamininb1chain,LAMB1-up:50-GGAACA
GCT CTC CAA GAT GG, and LAMB1-down: 50-CTG CTT CAA
TGC TGT CCA AA; for dipeptidylpeptidase IV (DPPIV), DPPIV-F:
50-AAG TGG CGT GTT CAA GTG TG, and DPPIV-R: 50-CAG
GGC TTT GGA GAT CTG AG; for villin, Vil1-F: 50-GGC CAG
CCA AGA TGA AAT TA, and Vil1-R: 50-CTC AAA GGC CTT
TGG TGG TGT; and for sucrase–isomaltase (SI), SI-S: 50-GAG
GACACTGGCTTGGAGAC,andSI-A:50-ATCCAGCGGGTA
CAG AGA TG. Ampliﬁcation efﬁciencies and assessment of
differencesingeneexpressionbetweencontrolsandexperimental
conditions were established according to the Pfafﬂ mathematical
model (Pfafﬂ, 2001). Relative mRNA expression levels were
established by comparing the levels from experimentals to those
from controls 100 (expressed as ‘‘% of control’’).
Migration and restitution assays
Twenty-four hours prior to wounding both HIEC and Caco-2/15
cells were treated with 2mM hydroxyurea in order to prevent
proliferation while leaving migration unaffected (Hamuro et al.,
2002). For HIEC, wound-healing assays were performed as
previously described (Dignass and Podolsky, 1993). The relative
migratory capacity was established by comparing the total number
of cells having migrated across the wound border in treated
cultures with thatof controls 100 (expressed as‘‘% ofcontrol’’).
For spreading assays, cells were plated onto glass coverslips (see
above) and processed for detection of vinculin by indirect IF to
monitor cell spreading after 4 and 18h (see above). Caco-2/15
siRNA-treated cells were plated at high density and grown until
conﬂuence (0 days PC) in 35mm dishes and monolayers were
wounded by aspiration with a 200-mL pipette tip (0.5–0.6mm
diameter) attached to a vacuum source. In all cases, wounds were
immediately rinsed and replenished with fresh complete media,
complemented or not with 3mg/cm
2 of exogenous ﬁbronectin
(Chemicon International). Wound areas were measured
numerically using the MetaMorph Imaging System (Universal
Imaging Corp., West Chester, PA) immediately following and 48h
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restitution of the original wounded area size. Only wounds
comparable in size and form were used in the statistical analyses.
Cell aggregate assays
Cell aggregate assays were established in order to simultaneously
evaluate cell spreading and migration abilities. Cells were treated
with 2mM hydroxyurea in order to prevent proliferation while
leaving migration unaffected (Hamuro et al., 2002). Cells from
cultures were detached with a 0.5M EDTA aqueous solution
(15minat378C),centrifuged4minat1,000gatroomtemperature,
and resuspended in 5ml of normal culture medium. Resuspended
cells were then transferred to 100mm polystyrene Petri dishes
previously blocked with a 2% BSA–PBS (pH 7.4) solution and
incubated 4h at 378C, with gently shaking every 30min. Cell
aggregates were then transferred to plastic culture dishes,
previouslycoatedornotwithﬁbronectin,andfurtherincubated1h
at 378C. After this time, cell aggregates of approximately 50–100
cells were observed with an inverted microscope (M40-82797,
Wild Heerbrugg, Leica Canada, Toronto) and marked. After a
further 24h, micrographs of the identiﬁed aggregates were taken
with the inverted microscope’s digital camera (RS Photometrics,
CoolSNAP, Tucson, AZ) and the area covered by the spread/
migrated cells was subsequently measured numerically using the
MetaMorphImagingSystem(UniversalImagingCorp.).Therelative
measure of spreading and migration was established by calculating
theratiosoftheareacoveredbycellsfromtheaggregatesoverthe
total number of cells in the spread aggregate compared to
controls 100 (expressed as ‘‘% of control’’).
Results
In vivo and in vitro expression of ILK and PIP complex
components in human IECs
We ﬁrst sought to establish the in vivo expression patterns for
ILK and other components of the PIP complex in the human
small intestine. In the functional ileum, ILK was found to be
localized at the basal plasma membrane of the intestinal
epitheliumalongtheentirelengthofthecrypt–villusaxis,butin
a clear expression gradient with stronger ILK staining in the
crypt compartment than in the villus (Fig. 1A). Components of
the PIP complex, namely PINCH-1 (Fig. 1B), a-parvin (Fig. 1C),
andb-parvin(datanotshown)werealsofoundtobeexpressed
in association with the basal plasma membrane of the intestinal
epithelium, and all displayed highly similar patterns of
decreasing expression along the crypt–villus axis as observed
for ILK. The antibody used to detect PINCH recognizes both
PINCH-1andPINCH-2;however,ithasbeenshownelsewhere
that PINCH-2 is not expressed in the intestinal epithelium and
mesenchymalcells(Braunetal.,2003).Epitheliallocalizationfor
ILK was conﬁrmed by co-detection of ILK with a BM
component, the laminin b1g1-chain, allowing for a clear
discrimination between the epithelial and underlying
mesenchymal populations of the crypt–villus axis (Fig. 1E–E00).
ILK was also found to be widely expressed throughout the
mesenchymal elements including smooth muscle and
endothelial cells (Fig. 1A,E). The in vivo intestinal expression
patterns of ILK, PINCH-1, a-parvin, and b-parvin were noted
toclosely follow thepreviously established decreasing gradient
of ﬁbronectin BM deposition along the crypt–villus axis
(Quaroni et al., 1978; Simon-Assmann et al., 1986; Beaulieu
et al., 1991; Fig. 1D).
We next conﬁrmed the in vivo expression of ILK and P1IP
complex components in IECs by RT-PCR analyses of intestinal
epithelium fractions that had been separated from the
underlying mesenchyme. Indeed, ILK, PINCH-1, a-parvin, and
b-parvinmRNAswerefoundtobereadilyexpressedinisolated
IECs (Fig. 1F). Epithelial and mesenchymal cell fraction purity
was conﬁrmed by monitoring the expression of vimentin, a
mesenchymalintermediateﬁlamentprotein,andE-cadherin,an
epithelial cell–cell junction protein (Fig. 1F). The expression of
RPLPO mRNA was used for normalization (Fig. 1F).
Protein expression of ILK and P1IP complex components
was analyzed by WB in two human IEC in vitro cell models,
HIEC and Caco-2/15. The crypt-like HIEC cells strongly
expressed ILK, PINCH-1, and a-parvin (Fig. 2A). These
proteins were all detected in Caco-2/15 cells and
interestingly, ILK, PINCH-1, and a-parvin were found to
decrease as a function of enterocytic differentiation (ILK,
68.9 6.6%; PINCH-1, 70.7 10.0%; and a-parvin,
63.9 7.2% decrease compared to 0 day PC values, n 3)
(Fig. 2A), thus mirroring their observed crypt-to-villus
gradients of expression in vivo. The two ubiquitously
expressed protein forms of b-parvin, b-parvin(l) and b-
parvin(s) (Sepulveda and Wu, 2006), were also detected in
both HIEC and Caco-2/15 cells; however, the (l) isoform was
clearly predominant (Fig. 2A). Furthermore, the expression of
these two b-parvin isoforms appeared to be distinctly
modulated as a function of enterocytic differentiation, where
b-parvin(l) levels increased and b-parvin(s) levels decreased
(b-parvin (l): 260.1 64.0% increase and b-parvin(s):
62.0 8.8% decrease compared to 0 day PC values, n 3)
(Fig. 2A). The expression of b-actin was used as a loading
control (Fig. 2A). HIEC cell extracts were used to conﬁrm
the organization of these proteins as a complex. A PINCH
antibody was used for immunoprecipitation and immunoblot
analyses of the IP showed that all members of the P1IP
complex co-immunoprecipitated with PINCH-1 (Fig. 2B). The
mouse monoclonal anti-HA was used as the IP control
antibody because this antibody does not recognize an antigen
in HIEC and is the same subtype as the PINCH-1 antibody
(IgG2a; Fig. 2B).
Indirect IF assays in HIEC cells stably transduced with a
cDNA coding for a V5-tagged wtILK were performed in
order to verify that ILK and P1IP complex components were
associated with focal adhesion points in adherent crypt IECs.
ILK was found to be predominantly located at the periphery
of the cells in a discrete punctuated pattern typical of focal
adhesion points (Fig. 3C), as observed with the focal adhesion
point component vinculin (Fig. 3A). Co-staining of vinculin
with the actin cytoskeleton showed that focal adhesion points
in HIEC were correctly positioned at the extremities of the
actin stress ﬁbers (Fig. 3B). PINCH-1, a-parvin, and b-parvin
(Fig. 3D–F) displayed intracellular localization patterns highly
similar to ILK and vinculin (Fig. 3A,C). These results
correlated with our in vivo observations that P1IP complex
components were found at the basal plasma membrane in
human IECs.
Takentogether,thesedataindicatethatILKispredominantly
expressed in human proliferative/undifferentiated IECs, and
most likely mediates formation of a PINCH-1–ILK–parvin
(P1IP) complex in addition to revealing a relationship between
thedecreasingcrypt-to-villusgradientofexpressionofthisP1IP
complexandthatofBMdepositionofﬁbronectin.Theseinturn
suggest a possible implication of the P1IP complex in cell
adhesion-mediated crypt IEC processes.
ILK knockdown leads to a severe disruption of the P1IP
complex in human crypt IECs
An siRNA approach was chosen to determine the functional
role of ILK in IECs: First, in undifferentiated/proliferative
HIEC cells, a state which appeared to express the highest
levels of ILK and then, in proliferative to differentiating Caco-
2/15 cells. Transient transfection of increasing concentrations
(10, 25, and 100mM) of an siRNA targeted against the human
ILK mRNA (siILK) in HIEC cells resulted in a signiﬁcant
decrease in ILK protein expression (Fig. 4A), in sharp
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control (Fig. 4A). ILK knockdown did not alter the expression
levels of focal adhesion kinase, FAK (Fig. 4A), nor did it
activate the OAS interferon response gene (data not shown)
suggesting that the ILK knockdown was efﬁcient and speciﬁc.
Further time-course experiments showed that the siRNA
knockdown of ILK was maintained over a period of at least
8 days post-transfection in both HIEC and Caco-2/15 cells
(Fig. 4B). Since it has been proposed that PINCH and parvins
form obligate complexes with ILK in order to avoid
proteasome degradation (Fukuda et al., 2003a), we evaluated
the impact of ILK knockdown on the expression of these
components in HIEC and Caco-2/15 cells. In siILK cells a
drastic loss of PINCH-1, a-parvin, and b-parvin expression
resulted from the knockdown of ILK (Fig. 4C). Furthermore,
as observed during the Caco-2/15 differentiation process
(Fig. 2A), b-parvin(s) is the only b-parvin isoform negatively
affected by the reduction of ILK levels (Fig. 4C), suggesting
that contrary to b-parvin(l), b-parvin(s) most likely depends
on P1IP complex formation to maintain its presence in
differentiating IECs. Therefore, these data indicate that the
speciﬁc knockdown of ILK in human IECs led to a severe
disruption of the P1IP complex in these cells.
ILK knockdown in human crypt IECs leads to a decrease
in ﬁbronectin deposition
Previous reports have implicated ILK in the deposition of
ﬁbronectin (Wu et al., 1998; Guo and Wu, 2002; Vouret-
Craviari et al., 2004; Assi et al., 2008) and we have observed a
correlation between the decreasing gradient of expression of
P1IP complex components and that of ﬁbronectin BM
deposition in vivo. We investigated the impact of ILK
knockdown on the ability of human IECs to produce and
deposit ﬁbronectin. We ﬁrst performed qPCR analyses on
HIEC cells to quantify and compare ﬁbronectin expression
levelsbetweensiILKandsiCNScells.Wefoundthatﬁbronectin
mRNA transcript levels were signiﬁcantly lowered following
the knockdown of ILK, but not under control conditions
(Fig. 5A). This decrease in ﬁbronectin mRNA levels was shown
tobespeciﬁc,aslevelsofthelamininb1-chainmRNAremained
unaffected (Fig. 5A). The same phenomenon was observed at
Fig. 1. ExpressionofILK,PINCH1,a-parvin,andﬁbronectininthehumansmallintestine.Immunolocalizationonhumanintestinalcryosections
of(A)ILK,(B)PINCH-1,(C)a-parvin,and(D)ﬁbronectinwithspeciﬁcantibodiesshowedstrongstaininginthebasalmembraneoftheepithelial
andmesenchymalcompartmentsalongthecrypt.PartsA–Dareacompositeofadjacentareas.Immunolocalizationof(E)ILKand(E()thelaminin
chainsalone(smallarrows)or(E(()togetherconﬁrmedthelocalizationofILKattheepithelialbasalmembrane(largearrows).F:Semi-quantitative
RT-PCR of ILK, PINCH-1, a-parvin, and b-parvin on intestinal epithelial and mesenchymal fractions showed epithelial and mesenchymal
expressionforeachprotein.VimentinandE-cadherinwereusedtocontrolforfractionpurity,andRPLPOwasusedasanormalizinggene.NTC,no
template control; c, crypts; v, upper half of the villus. A–D: Scale bar in (A): 50mm; in (E–E00), scale bar in (E): 20mm.
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expressed lower amounts of ﬁbronectin than siCNS-treated
cells (39.0 10.3% of siCNS values, n¼5.)
Because ﬁbronectin is ﬁrst secreted by cells as a compact
soluble form before it is deposited in the ECM through
ﬁbrillogenesis (Mao and Schwarzbauer, 2005), the levels of
soluble ﬁbronectin present in the culture media of treated and
non-treated HIEC cells were also determined. Surprisingly,
levels of secreted, soluble ﬁbronectin in the culture media of
siILKcellsremainedsimilartothosedetectedinsiCNScellsfor
both(106.3 15.5%ofsiCNSvalues,n¼5),aswasthecasefor
secreted, soluble laminin (Fig. 5B). These results suggest that
despitelower cellularﬁbronectinexpression,cellsdeﬁcientfor
ILKaccumulate comparable levels ofﬁbronectin inthemedium
than control cells as a consequence of inefﬁcient ﬁbronectin
deposition. This prompted us to investigate whether the
knockdown of ILK impacted on the actual deposition of
ﬁbronectin in human IECs. We monitored the capacity of siILK
versussiCNSHIECcellstoformaninsolubleﬁbronectinmatrix
with the available soluble ﬁbronectin in culture media by
isolating deposited ECM fractions from these cultures. We
found that ILK knockdown led to a substantial decrease in
ﬁbronectin deposition (10.6 3.5% of siCNS values, n¼5)
compared to control cells (Fig. 5B). This observed decrease
appeared to be speciﬁc for ﬁbronectin, since the levels of
laminin b1g1-chains found in the ECM remained unaffected. A
signiﬁcant reduction in ﬁbronectin deposition was also
observed in siILK versus siCNS-treated Caco-2/15 (data not
shown). Lastly, in situ indirect immunoﬂuorescence assays in
non-permeabilized HIEC cell cultures showed less intense and
lessextensivestainingforﬁbronectinECMdepositionfollowing
the knockdown of ILK (Fig. 5D), in comparison to control cells
(Fig. 5C). Taken together, these results demonstrate that the
knockdown of ILK in human IECs impacted negatively on both
the synthesis and the deposition of ﬁbronectin.
Sinceﬁbronectin depositionisaffected byILK knockdownin
IECs we veriﬁed whether the expression levels of the
ﬁbronectin integrin receptors a5b1 and aV-containing
integrins were affected. WB analyses of the a5 and aV subunit
proteinlevelsinHIECcellsshowedequalamountsofthea5and
aV integrin subunits between siILK- and siCNS-treated cells
(Fig.5E).ThisresultindicatesthatILKknockdowndidnotaffect
integrin ﬁbronectin receptor expression.
ILK knockdown decreases spreading, migration, and
restitution of human IECs
Considering that P1IP complex components are associated
with focal adhesion points in our cell model, and that the
knockdownofILKresultednotonlyinadecreaseofﬁbronectin
ECM deposition but also in a severe disruption of the P1IP
complex, we determined whether ILK knockdown likewise
affected the spreading ability and migration capacity of human
crypt IECs. siILK- and siCNS-treated HIEC cells were seeded
ontoglasscoverslipsandtheformationoffocaladhesionpoints
byinsituindirectIFstainingforvinculinwasfollowedovertime.
At 4h post-seeding, both siILK and siCNS cells showed similar
ratesofadhesionalthoughsiILKcellsappearedtobelessspread
than control cells, as visualized by the peripheral localization of
vinculin (Fig. 6A). After 18h, siCNS cells were found to have
spread considerably, as evidenced by the extensive display of
elongated punctuate patterns of vinculin localization (Fig. 6A)
typical of mature focal adhesion points (Geiger et al., 2001). In
sharp contrast, siILK cells remained rounded and largely
displayed the peripheral dot-like vinculin localization pattern
(Fig. 6A) typical of the immature focal adhesion points called
focal complexes (Geiger et al., 2001). Hence, these results
showed that ILK was not essential for the initial attachment of
human crypt IECs but was nonetheless crucial for their
subsequent spreading and formation of mature focal adhesion
points.
We next veriﬁed whether the cell spreading deﬁciency seen
insiILKcellsaffectedcryptIECmigrationbyperformingscratch
woundhealingassays.AsshowninFigure6B,signiﬁcantlylower
numbers of siILK cells were found to have migrated into the
wounded area than siCNS cells. These data indicate that ILK
performs a key role in human crypt IEC migration.
A second type of migration found in the polarized intestinal
epithelium is restitution, which consists of the resealing of
superﬁcial wounds by epithelial sheet movement. The
restitution process is a complex phenomenon which does not
involve proliferation but requires that the differentiated
epithelial cells ﬂatten, spread, and migrate in order to close the
wound (Mammen and Matthews, 2003). Since restitution has
already been shown to be, at least in part, modulated by the
ECM (Zhang et al., 2006) we examined the effect of ILK
depletion onCaco-2/15restitution ability. Results showed that
wound closure in newly formed siILK-treated Caco-2/15 cell
monolayers was signiﬁcantly less (62.7 3.0% of the original
wound area size) than closure of the wound area in siCNS-
treated Caco-2/15 control cells (74.5 3.4%) over the same
time period (Fig. 6C). These data point to a role for ILK in the
human villus IEC restitution mechanism.
Fig. 2. Regulation of P1IP complex members during proliferation in
differentiating intestinal epithelial cells. A: Representative Western
blot analyses of whole cell lysates of HIEC and Caco-2/15 cells at
different stages of post-conﬂuence (0–30 days) using speciﬁc
antibodies directed against members of the P1IP complex. ILK,
PINCH-1, a-parvin, and b-parvin were expressed in our in vitro
models. PINCH-1, ILK, a-parvin, and b-parvin(s) (lower band)
expression decreased during Caco-2/15 differentiation. b-parvin(l)
(upperband)increasedduringthedifferentiationprocess.b-actinwas
used as a loading control. Representative Western analysis of
experiments carried out at least three times independently. B: Co-IP
of the P1IP members using PINCH antibody and HA-probe antibody
as control on HIEC cells. Immunoblot analysis shows co-
immunoprecipitation of ILK, a-parvin, and two isoforms of b-parvin
with PINCH-1. Representative Western analysis of experiments
carried out three times independently. PC, post-conﬂuence.
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human IECs
Since both ILK and ﬁbronectin have independently been
reported to be involved in the control of cell proliferation
(Danen and Yamada, 2001; McDonald et al., 2008), we tested
whetherknockdownofILKcouldalsonegativelyimpacthuman
IEC proliferation. To this effect, cell proliferation assays (BrdU
incorporation) of siILK and siCNS cells cultured on plastic
dishes were performed. As shown in Figure 7A, the
Fig. 3. LocalizationofP1IPmembersatfocaladhesionsitesinHIECcells.Cellswereplatedonglasscoverslips,ﬁxed,andstainedwithdifferent
speciﬁcantibodiesagainst(A)vinculin(green)or(B)vinculin(green)co-localizedwithF-actin(red),(C)V5-ILK,(D)PINCH-1,(E)a-parvin,and(F)
b-parvin.Stainingpatternsweretypicaloffocaladhesionpoints.A–F:Scalebarin(A):10mm.Representativeimagesofexperimentscarriedoutat
least three times independently.
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cells was found to be signiﬁcantly reduced compared to
controls. Parallel WB analyses were performed on the normal
HIECcellsinordertoconﬁrmthatthisdecreaseinproliferation
was consequent to a deregulation of cell-cycle progression
regulatory elements. Indeed, siILK-treated HIEC cells showed
sharp increases in the levels of hypophosphorylated pRb and of
the cell-cycle inhibitor p27, accompanied by the loss of cyclin
D1 levels (Fig. 7B). Levels of expression of the cell-cycle
inhibitor p21 remained constant. Therefore, these results
indicatethatILKperformscrucialfunctionsinthemodulationof
key regulatory elements of cell-cycle progression of human
crypt IECs, thus constituting a molecular basis for ILK’s role in
stimulating the proliferation of these cells.
We then plated siILK- and siCNS-treated HIEC cells onto
exogenously deposited ﬁbronectin and performed additional
cell proliferation assays. The proliferation index of siILK-
treated HIEC cells was increased when plated on exogenous
ﬁbronectin(Fig.7A),essentiallyreversingtolevelsobservedfor
siCNS-treated HIEC cells on plastic (Fig. 7A), although still
signiﬁcantly lower than that of siCNS-treated HIEC cells on
ﬁbronectin (Fig. 7A). Similar results were obtained using Caco-
2/15 cells. Knockdown of ILK in Caco-2/15 cells signiﬁcantly
reduced the proliferation index in cells grown on plastic
(Fig. 7A) whereas it was restored when these cells were plated
on ﬁbronectin (Fig. 7A). Interestingly, exogenous ﬁbronectin
didnotincreasetheproliferationindexofsiCNS-treatedCaco-
2/15 cells (Fig. 7A). These results indicate a key role for ILK in
the deposition and organization of ﬁbronectin into a functional
matrix by human IECs, which in turn constitutes a major
element in driving their proliferation.
Exogenous ﬁbronectin rescues the ILK knockdown
phenotype in human IECs
WethensoughttoconﬁrmthedirectrelationshipbetweenILK
knockdown, decreased ﬁbronectin deposition, and decreased
cell spreading, migration, and restitution. We ﬁrst performed
cell aggregate assays with HIEC cells, which allow for the
simultaneous analysis of cell spreading and migration
capabilities(Fig.8A).Wealsocarriedoutrestitutionassayswith
andwithoutﬁbronectinonCaco-2/15cellmonolayers(Fig.8B).
Whenonplasticalone,siILK-treatedcellsexhibitedsigniﬁcantly
lower spreading/migration and restitution capacities than
control siCNS-treated cells (Fig. 8A,B), as expected from our
previousresultsabove.Thepresenceofexogenousﬁbronectin
successfully reversed the spreading/migration and restitution
reductions observed in siILK cells. Exogenous ﬁbronectin had
no net effect on control siCNS cells (Fig. 8A,B). In order to
conﬁrm that the previous exogenous ﬁbronectin functional
Fig. 4. siRNAinhibitionofILKexpressioninIECcells.A:HIECcellsweretransfectedwith10,25,or100mMofsiRNAdirectedagainstILK(siILK),
100mMofanon-silencingnegativecontrolsiRNA(siCNS),orwithoutsiRNA(WT)andmonitoredforILKexpression.WesternanalysisforFAKand
b-actin protein levels was used as controls for siRNA speciﬁcity and loading, respectively. B: HIEC and Caco-2/15 cells transfected with 40mMo f
siILKorthenon-silencingnegativecontrolsiCNSwereanalyzedbyWesternblotforILKexpressionasafunctionoftime(HIEC,4–10days;Caco-2/
15,5and8days).b-actinwasusedasaloadingcontrol.C:HIECandCaco-2/15cellsweretransfectedwith40mMsiILK,harvestedafter72h(Caco-2/
15cellswereat0daysPC),andanalyzedbyWesternblotusingspeciﬁcantibodiesagainstILK,PINCH-1,a-parvin,andb-parvin.b-actinwasusedas
aloadingcontrol.siILKcausedadecreaseinexpressionofallP1IPcomponentsinbothcelltypes.RepresentativeWesternanalysisofexperiments
carried out at least three times independently. WT, wild type.
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salvage of some P1IP members, we next investigated the
individual levels each P1IP member in these cells. WB analyses
showed no signiﬁcant rescue of PINCH-1 nor a-parvin in ILK
knocked down HIEC by ﬁbronectin (Fig. 8C). These results
indicatethatthedecreaseofﬁbronectindepositioninsiILKcells
wasdirectlyresponsibleforthereductioninIECcellspreading,
migration, and restitution.
ILK knockdown does not inﬂuence human IEC
differentiation
We next veriﬁed if the reduction of ILK had an impact on the
differentiation of Caco-2/15 cells by monitoring the expression
ofDPPIV,villin,andSI,allofwhicharetypicalmarkersofintestinal
epithelial differentiation (Beaulieu and Quaroni, 1991; Vachon
and Beaulieu,1992; Tremblay etal.,2006). Caco-2/15cells were
infectedunderthesameconditionsasinFigure4Bandharvested
6 days after conﬂuence (corresponding to 9 days post-infection,
see the Materials and Methods Section for details). Quantitative
PCR revealed that the expression of the three tested markers
was not altered by the ablation of ILK expression (Fig. 9). This
indicates that ILK is not directly implicated in the control of
cellular differentiation of human IECs.
Discussion
Inthepresentstudy,weinvestigatedtheexpressionandroleof
ILK in human IECs in vivo and in vitro. Herein, we report that
the expression patterns of ILK, PINCH-1, a-parvin, and b-
parvin along the crypt–villus axis decreased as a function of
enterocytic differentiation and followed the BM distribution of
ﬁbronectin, that is, being largely predominant in human
proliferative/undifferentiated crypt IECs. In these cells, ILK,
PINCH-1, a-parvin, and b-parvin were closely associated with
focal adhesion points. The siRNA knockdown of ILK in human
IECscausedaseveredisruptionofP1IPcomplexesalongwith a
signiﬁcant decrease in cell proliferation (decrease of cyclin D1,
increase in p27 and hypophosphorylated pRb), as well as
spreading (persistence of immature focal adhesion points)
migration and restitution capabilities. The ILK knockdown-
induced defects in spreading, migration, restitution, and
proliferationweredirectlyrelatedtoaconcomitantdecreasein
ﬁbronectin synthesis and ECM deposition and were reversed
with exogenously deposited ﬁbronectin. Hence, ILK performs
these key roles in human IECs, most likely as part of a P1IP
complex.
A primary function of ILK is to mediate the formation of
PIP complexes in a variety of tissues, where the exact
PINCH/parvin composition, and consequently their speciﬁc
roles in cell processes, may be cell and tissue context-
dependent (Legate et al., 2006; Sepulveda and Wu, 2006;
McDonald et al., 2008). Our ﬁndings not only further support
the concept of an absolute requirement of the scaffolding
function of ILK for the formation and maintenance of active
PIP complexes at focal adhesion points but additionally reveal
that the levels of the PIP complex may change depending on
Fig. 5. Knockdown of ILK expression inhibits IEC cell ﬁbronectin
deposition.HIECcellsweretransfectedwith40mMofsiCNSorsiILK.
A: Real-time PCR was carried out on HIEC cells to measure levels of
ILK, ﬁbronectin (FN), and laminin b1-chain (LNb) mRNA levels in
siCNS-transfected cells (gray columns) versus silk-transfected cells
(white columns). siILK cells showed a signiﬁcant decrease in ILK and
ﬁbronectin mRNA levels. Results are expressed as meanWstandard
error of the mean (SEM) and are from three independent
experiments.
MMMP<0.001inaone-samplet-testwiththehypothetical
mean of 100 for the normalized values of siCNS. B: Protein levels of
ﬁbronectin and the laminin b1g1-chains were analyzed in the
medium, in the insoluble matrix, and in whole cell lysates of HIEC
siCNS and siILK cells, and a decrease of ﬁbronectin levels was
observed in siILK cell insoluble matrix and whole cell lysates.
RepresentativeWesternimagesfromﬁveindependent experiments.
Indirect immunoﬂuorescence of insoluble ﬁbronectin on HIEC (C)
siCNS and (D) siILK cells. C,D: Scale bar in (C): 10mm. E:
Representative Western blot analysis of the a5 subunit of the a5b1
integrin and aV subunit of the aV-containing integrins from siCNS-
and siILK-treated HIEC showing no signiﬁcant variation in three
separateexperiments.[Colorﬁgurecanbeviewedintheonlineissue,
which is available at www.interscience.wiley.com.]
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Indeed, our results showed that proliferative/undifferentiated
crypt IECs express high levels of P1IP complex components
whereas non-proliferative/differentiated villus IECs express
low levels. Our results also suggest that a-parvin and b-
parvin(s) have exclusive roles in the context of the PIP
complexes in IECs since a-parvin and b-parvin(s), but not b-
parvin(l), follow the decline in PINCH-1 and ILK protein
levels in differentiating Caco-2/15, as well as in siILK-treated
HIEC and Caco-2/15 cells. Consequently, further
investigation will be required to fully comprehend the precise
roles of the distinct PIP complexes in human IECs.
Fig. 6. KnockdownofILKexpressioninhibitsHIECcellspreadingandmigrationandCaco-2/15monolayerrestitution.HIECorCaco-2/15cellswere
transfectedwith40mMofsiCNSorsiILK.A:TransfectedHIECcellswereplatedonplasticandobservedat4and18h,ﬁxed,andstainedforvinculin.
Scalebar:20mm.B:siRNA-treatedHIECweregrownonplasticuntilconﬂuenceandwoundedwitharazorblade.Cellswhichhadmigratedintothe
woundedareaafter48hwerecountedandexpressedasapercentageofcontrolcells.ResultsareexpressedasmeanWstandarderrorofthemean
(SEM)andarefromthreeindependentexperiments.
MMP<0.01inaone-samplet-testwiththehypotheticalmeanof100forthenormalizedvaluesof
siCNS.C:siRNA-treatedCaco-2/15cellsweregrownuntilconﬂuenceandthemonolayerwaswoundedbyaspiration.Originalwoundandremaining
woundareaswherecellshadnotclosedtheoriginalwoundafter48hweremeasuredandtheresultsareexpressedasapercentageoftherestitutionof
theoriginalwoundedarea.ResultsareexpressedasmeanWstandarderrorofthemean(SEM)andarefromthreeindependentexperiments.
MP<0.05
in a paired t-test. Scale bar: 100mm. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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direct relationship in human small intestinal cells between the
functional expression of ILK and the capacity for ﬁbronectin
synthesisandfunctionalmatrixdeposition.Theoverexpression
of ILK has previously been shown to increase ﬁbronectin ECM
deposition in rat IECs (Wu et al., 1998) and the intestine-
speciﬁc knockout of ILK in mice, as well as the siRNA
knockdown of ILK in SW480 colon cancer cells, were recently
shown to result in the decrease of ﬁbronectin mRNA and
proteinexpressionlevels(Assietal.,2008).Hence,ourﬁndings
not only corroborate the observations from these previous
studies,butfurthermoreshow,fortheﬁrsttime,animplication
of the P1IP complex—and not just ILK—in the process of
ﬁbronectin synthesis and functional BM deposition in human
IECs. Interestingly, expression levels of P1IP members show a
decreasing gradient in differentiating Caco-2/15 cells which
correlates with the decreasing gradient of ﬁbronectin
expression in these cells previously reported by ourselves
(Vachon et al., 1995), as well as with our observations in the
small intestinal epithelium and BM shown herein. The
Fig. 7. Knockdown of ILK expression inhibits HIEC cell
proliferation. HIEC and Caco-2/15 cells were transfected with 40mM
of siCNS or siILK. A: Proliferation indexes were determined by BrdU
incorporation on transfected cells that were seeded on plastic or on
exogenous ﬁbronectin, and stained using an anti-BrdU antibody.
BrdU-positive cells were counted and expressed as a percentage of
total cells determined by DAPI staining. Results are expressed as
meanWstandard error of the mean (SEM) and are from three
independent experiments.
MP<0.05 in a paired t-test. B: HIEC-
transfected cells were analyzed by Western blot for protein
expression levels of ILK, pRB (upper band, hyperphosphorylated
form; lower band, hypophosphorylated form), cyclin D, p21, and p27.
b-actin was used as a loading control. Representative Western
analysis is from at least three independent experiments. n.s., not
signiﬁcant.
Fig. 8. Exogenous ﬁbronectin rescued spreading, migration, and
restitutionofsiILKcells.HIECorCaco-2/15cellsweretransfectedwith
40mM of siCNS or siILK. A: HIEC cell aggregates (50–100cells) were
platedonplasticorexogenousﬁbronectinandanalyzedafter24h.The
areacoveredbythespread/migratedcellswassubsequentlymeasured
andtherelativemeasureofspreadingandmigrationwasestablishedby
calculating the ratios of the area covered by cells from the aggregates
over the total number of cells in the spread aggregate compared to
controlsT100 (expressed as ‘‘%o fc o n t r o l ’’). Results are expressed as
meanWstandard error of the mean (SEM) and are from at least three
independent experiments.
MMMP<0.001 in a one-sample t-test with the
hypotheticalmeanof100forthenormalizedvaluesofsiCNS.B:siRNA-
treated Caco-2/15 cells were grown until conﬂuence and the
monolayers were wounded by aspiration. Exogenous ﬁbronectin was
then added or not to the culture medium. Areas where cells had not
coveredtheoriginalwoundafter48hweremeasuredandexpressedas
a percentage of the original wounded area. Results are expressed as
meanWstandard error of the mean (SEM) and are from at least three
independent experiments.
MP<0.05;
MMMP<0.001 in a paired t-test. C:
siILK- and siCNS-treated HIEC cells were plated and grown on plastic
or ﬁbronectin for 48h. The cells were then harvested and analyzed by
Western blot. Fibronectin did not rescue the decrease of the PIP
components caused by siILK treatment. b-actin was used as a loading
control. n.s., not signiﬁcant.
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(Alonsoet al., 1996;Gradletal., 1999)thathavebeenshownin
other cell systems to be potentially regulated by ILK-mediated
signaling (Legate et al., 2006; McDonald et al., 2008), thus
providing a molecular basis for the relationship between the
loss of ILK (and the P1IP complex) and the consequent
reduction in ﬁbronectin mRNA transcription. However, this
alonecannotaccountfortheobservedreductioninﬁbronectin
deposition, since knockdown of ILK did not affect the net
amount of ﬁbronectin found in the culture medium. Such
apparently contrasting observations are likely the result of the
different soluble ﬁbronectin deposition abilities between
control and ILK-treated cells. A previous study in rat IECs
reported that overexpression of ILK prompted the co-
localizationoftheﬁbronectinintegrinreceptor,a5b1,withthe
focaladhesionpointcomponentvinculin(Wuetal.,1998).This
observation is consistent with the established requirement of
ﬁbronectin integrin receptors for ﬁbrillogenesis and ECM
deposition (Mao and Schwarzbauer, 2005). Our ﬁndings show
that the expression levels of ﬁbronectin receptors are
unaffected by the loss of ILK, suggesting that these receptors
remain physically available for binding. However, this does not
exclude that a scaffolding, and/or a signaling, defect constitutes
the driving cause for the observed decrease in ﬁbronectin
deposition.Indeed,thereisarequirementforactincytoskeletal
tension, generated at focal adhesion points by stress ﬁbers, in
enablingﬁbrillogenesis(Baneyxetal.,2002;Yonedaetal.,2007).
Our ﬁnding that the knockdown of ILK results in IECs forming
immature focal adhesion points suggests that the loss of ILK
(and consequently the P1IP complex) greatly reduces the actin
cytoskeletal tension so necessary for ﬁbrillogenesis—and
consequently impacts negatively on the deposition of
ﬁbronectin. Alternatively, various signaling molecules such as
PI3-K, Src, and MEK/Erk have also been shown to regulate the
deposition of ﬁbronectin in various cell types (Hughes et al.,
1997; Brenner et al., 2000; Wierzbicka-Patynowski and
Schwarzbauer, 2002). Since these can be regulated by ILK and
PIPcomplexes(Delcommenneetal.,1998;Fukudaetal.,2003b;
Kimet al.,2008),theirderegulationmayalsoinpartexplainthe
reduction of ﬁbronectin deposition that is consequent to a
knockdown of ILK. Further studies will be required to gain a
better understanding of the molecular basis of the functions of
PIP complexes in ﬁbronectin synthesis and ECM deposition, as
well as to ﬁrmly establish whether the kinase activity of ILK, its
scaffoldingfunction,orboth,arerequiredinthisprocess.Inthis
respect, a previous study in rat IECs reported the requirement
fortheintegrityoftheILKkinasedomainintheup-regulationof
ﬁbronectin deposition, following overexpression of ILK (Wu
et al., 1998).
Another key ﬁnding in the present study is the
demonstration of a direct relationship in human crypt IECs
between the functional expression of ILK and the capacity for
ﬁbronectin matrix deposition, which then regulates spreading,
migration, and cell-cycle progression. Fibronectin is well
recognized as a key component in the regulation of various cell
processes (Wierzbicka-Patynowski and Schwarzbauer, 2003).
Its predominant deposition in the BM underlying the crypts
correlates with the presence of actively proliferating and
migrating IECs in this intestinal epithelial compartment (Pageot
etal.,2000).Theseﬁndings,togetherwithourobservationthat
thedifferentiationprocessofsiILK-treatedCaco-2/15cellsisin
no way altered, support previous reports that ﬁbronectin does
not affect enterocytic differentiation (Kedinger et al., 1987;
Hahn, 1988; Hahn et al., 1990), but rather stimulates IEC
spreading, migration, and proliferation (Goke et al., 1996;
Kuwada and Li, 2000; Hagerman et al., 2006; Zhang et al., 2006;
Assi et al., 2008). It is therefore not surprising that the ILK
knockdown-induced deﬁciency of ﬁbronectin deposition in
human crypt IECs was concomitantly accompanied by
deﬁciencies in their spreading, migratory, and proliferative
capacities (this study). Furthermore, our results also support a
role for a ﬁbronectin/ILK-dependent mechanism in the
restitution ability of villus IECs. As we reported herein and
elsewhere,mature(non-proliferating/differentiated)villusIECs
express low levels of P1IP complex members (this work), as
well as low levels of ﬁbronectin (this work) (Vachon and
Beaulieu, 1992) compared to their proliferative/
undifferentiated crypt counterparts. However, differentiated
enterocytes need to dedifferentiate in order to initiate and
complete the restitution process (Basson, 2001). Considering
that ﬁbronectin has already been shown to promote intestinal
restitution (Zhang et al., 2006), it can therefore be expected
that dedifferentiated cells present at the wound borders may
‘‘re-express’’ increased levels of P1IP complexes and
ﬁbronectin during the restitution process. These data, coupled
with our additional observation that exogenously deposited
ﬁbronectin rescued the ILK knockdown phenotype, clearly
demonstrated a critical regulatory role for ILK and ﬁbronectin
in the maintenance of human intestinal crypt–villus axis
homeostasis.
Although ILK and PIP complexes have been implicated in
various cell processes such as spreading and migration
(SepulvedaandWu,2006;McDonaldetal.,2008),theirrolesin
theseprocessesinIECshaveremainedpoorlyunderstood.We
have shown that the loss of ILK (and the P1IP complex) in
human cryptIECs notonly resulted indefectsin the formation/
assembly of mature focal adhesion points but also led to
signiﬁcant defects in spreading and migration. However, other
focal adhesion components, such as FAK and vinculin, which
have been previously shown to be sufﬁcient for spreading and
migration (Panetti, 2002; Ziegler et al., 2006), remained
unaffected by the knockdown of ILK. This would explain why
exogenously deposited ﬁbronectin fully rescued the ILK
knockdownphenotypewithregardtospreadingandmigration.
Fig. 9. Knockdown of ILK expression does not inﬂuence the
differentiation process. Caco-2/15 cells were transfected with 40mM
of siCNS or siILK. Real-time PCR was carried out to measure DPPIV,
villin, and sucrase–isomaltase (SI) mRNA levels in siCNS cells (gray
columns)versussiILKcells(whitecolumns).AbolitionofILKinCaco-
2/15 cells did not signiﬁcantly change DPPIV, villin, and SI transcript
levels at 6 days PC. Results are expressed as meanWSEM and are
from three independent experiments. Statistical analysis was one-
sample t-test with the hypothetical mean of 100 for the normalized
values of siCNS. n.s., not signiﬁcant; PC, post-conﬂuence.
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P1IP complex signiﬁcantly reduced spreading and migration in
human crypt IECs, without managing to fully abrogate these
processes. Indeed, while ﬁbronectin is a principal activator of
IEC spreading and migration, it is not the only intestinal BM
component to exhibit this ability (Goke et al., 1996; Beaulieu,
1997;TellerandBeaulieu,2001).Inanyevent,muchremainsto
be understood of the molecular contributions of ILK and P1IP
complexes in their ﬁbronectin-dependent regulation of
spreading and migration in human crypt IECs.
Althoughproliferationisadhesiondependentinnormalcells
(Moschos et al., 2007), various elements of this process are
distinct to those which mediate spreading and migration (Lock
etal.,2008).WhileILKandPIPcomplexeshavebeenimplicated
in the regulation of cell proliferation (Sepulveda and Wu, 2006;
McDonaldetal.,2008),theirrolesinthisprocessinIECsremain
to be understood. For instance, whereas a role for ILK in
intestinal tumorigenesis is becoming increasingly established
(Bravou et al., 2006; Assi et al., 2008), it has only recently been
reported in mice that ILK is implicated in the stimulation of
normal IEC proliferation and in the maintenance of crypt size
(Assietal.,2008).Inthepresentstudy,wehaveshownthatILK
and the P1IP complex are predominantly expressed by human
crypt IECs in vivo and in vitro and follow the BM deposition
pattern of ﬁbronectin along the crypt–villus axis. To this effect,
exogenously deposited ﬁbronectin fully restored proliferation
in ILK knockdown human crypt IECs. In addition to a5b1,
proliferative/undifferentiated (crypt) IECs may also use the
integrins aVb3 and/or aVb5a sﬁbronectin receptors (Zhang
et al., 2003). The integrin receptor a5b1 engages and activates
ILK-mediatedsignalinguponbindingﬁbronectin(Gopalakrishna
et al., 2000; Vouret-Craviari et al., 2004; Camacho-Leal et al.,
2007). Furthermore, ﬁbronectin has been previously reported
tostimulateILKactivityinratIECs(Delcommenneetal.,1998),
whereas the overexpression of ILK in these same cells
increased the expression of cyclin D1 (Radeva et al., 1997).
Previous work has reported that ILK (and PIP complexes) can
contribute to the activation of signaling pathways that are
implicatedintheregulationofcellproliferation,suchasSrc,Akt,
GSK-3,andMEK/Erk(Legateetal.,2006;Naskaetal.,2006;Kim
etal.,2008).ThelossofILK(andoftheP1IPcomplex)inhuman
IECsresultedinagrossderegulationofkeyregulatoryelements
of cell-cycle progression (namely pRb, p27, and cyclin D1).
Taken together these observations not only strongly support a
major role for ILK (and the P1IP complex) in the ﬁbronectin-
mediateddrivingofhumancryptIECproliferationbutalsobegin
to provide a molecular basis for such a role. However, those
same proliferation-regulating pathways that are susceptible to
being activated by ILK and PIP complexes following binding to
ﬁbronectin can likewise be engaged by the signaling of various
other ECM/BM components and their receptors, as well as by
growth factor receptors. It is therefore possible that ILK-
deﬁcient IECs are unable to unfold and organize exogenous
ﬁbronectin into a ﬁbril matrix, and as a result affect the
organization of the ECM/BM itself (Sottile and Hocking, 2002).
Consequently, this may explain why exogenously deposited
ﬁbronectin fully restored proliferation in ILK knockdown
humancryptIECs,yetatthesametimefailedtofurtherenhance
proliferation in these same cells, to levels observed in ILK-
expressing/controlcells.Inturn,thiswouldalsoexplainwhythe
loss of ILK and of the P1IP complex signiﬁcantly reduced
proliferation in human crypt IECs but did not manage to fully
abrogate the process. Therefore, additional studies will be
required in order to further identify the signaling basis which
underlies the role of ILK in the regulation of cell-cycle
progression in human crypt IECs.
In conclusion, this study has provided evidence that ILK, and
by extension the P1IP complex, performs crucial functions in
thecontrolofcriticaladhesion-mediatedcellprocessesthatare
required for human intestinal crypt and villus cell
homeostasis—namely ﬁbronectin synthesis and BM
deposition, as well as cell spreading, migration, restitution, and
proliferation. In addition to the present ﬁndings, further
investigation of these ﬁbronectin-driven, ILK-mediated IEC
processes should provide greater knowledge of the
complexities involved in the maintenance, renewal, and healing
of the human intestinal epithelium—both under normal
physiological conditions and within the context of
physiopathologies such as inﬂammatory bowel disease and
cancer.
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